Table 2.
Characteristics of neoadjuvant therapy-related adverse events and acute surgical complications in the studied patients.
| Variable | Patients who have undergone surgery(n=32) | Non-operated patients (n=13) | Total (n=45) |
|---|---|---|---|
| Hematologic | |||
| Neutropenic fever | 0 (0%) | 0 (0%) | 0 (0%) |
| Grade 3 thrombocytopenia | 0 (0%) | 0 (0%) | 0 (0%) |
| Grade 3 neutropenia | 4 (12.5%) | 3 (23.1%) | 7 (15.6%) |
| Grade 3 anemia | 0 (0%) | 0 (0%) | 0 (0%) |
| Acute kidney injury | 1 (3.1%) | 1 (7.7%) | 2 (4.4%) |
| Oral mucositis | 0 (0%) | 0 (0%) | 0 (0%) |
| Odynophagia | |||
| No odynophagia | 10 (31.3%) | 7 (53.8%) | 17 (37.8%) |
| Grade 1 odynophagia | 8 (25%) | 3 (23.1%) | 11 (24.4%) |
| Grade 2 odynophagia | 11 (34.4%) | 3 (23.1%) | 14 (31.1%) |
| Grade 3 odynophagia | 3 (9.4%) | 0 (0%) | 3 (6.7%) |
| Acute Surgical Complications | |||
| No complications | 25 (78.1%) | – | – |
| Pleural effusion | 2 (6.3%) | – | – |
| Sepsis | 3 (9.4%) | – | – |
| Anastomotic leak | 1 (3.1%) | – | – |
| Hydropneumothorax | 1 (3.1%) | – | – |
" - " means this is not applicable for those patients.